Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally. It develops drugs in the areas of diabetes and anti-cancer. The company also offers drug substances, general medicines, health functional foods, and nutrition and health products and services. In addition, it operates an online pharmacy; and offers pharmaceutical management automation systems. The company was formerly known as Hanmi Holdings Co., Ltd. and changed its name to Hanmi Science Co., Ltd. in March 2012. Hanmi Science Co., Ltd. was founded in 1973 and is based in Seoul, South Korea.
Revenue of Hanmi Science Co., Ltd. (008930.KS)
Revenue in 2023 (TTM): $904.48 M
According to Hanmi Science Co., Ltd.'s latest financial reports the company's current revenue (TTM) is $904.48 M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history of Hanmi Science Co., Ltd.
Annual Revenue
| Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
|---|---|---|---|---|---|
| 2023 | $904.48 M | $164.43 M | $47.65 M | $45.72 M | $83.44 M |
| 2022 | $758.18 M | $73.71 M | $61.31 M | $53.04 M | $50.16 M |
| 2021 | $688.68 M | $96.23 M | $42.05 M | $35.6 M | $31.12 M |
| 2020 | $621.43 M | $87.49 M | $27.85 M | $21.72 M | $16.38 M |
| 2019 | $591.88 M | $78.52 M | $32.22 M | $25.68 M | $22.28 M |
| 2018 | $513.15 M | $66.98 M | $18.62 M | $13.64 M | $13.06 M |
| 2017 | $472.8 M | $20.52 M | $28.49 M | $24.21 M | $21.79 M |
| 2016 | $482.2 M | $20.06 M | $17.03 M | $13.71 M | $5.75 M |
| 2015 | $562.6 M | $113.56 M | $172.8 M | $169.41 M | $129.39 M |
| 2014 | $386.03 M | $384.95 M | $16.67 M | $13.53 M | $15.45 M |
| 2013 | $159.36 M | $158.3 M | $9.33 M | $7.57 M | $6.94 M |
| 2012 | $14.24 M | $14.24 M | $10.99 M | $9.32 M | $9.04 M |
| 2011 | $12.19 M | $12.19 M | $4.14 M | $2.85 M | $-10,647,634 |
| 2010 | $464.94 M | $265.97 M | $29.95 M | $-4,680,490 | $4.33 M |
| 2009 | $500.08 M | $304.5 M | $90.14 M | $45.24 M | $36.62 M |
| 2008 | $439.81 M | $283.01 M | $48 M | $68.06 M | $51.86 M |
| 2007 | $385.15 M | $258.64 M | $74.31 M | $57.39 M | $38.41 M |